Aker BioMarine ASA (OSL:AKBM)
Norway · Delayed Price · Currency is NOK 99.40
+0.40 (0.40%)
Jun 19, 2026, 4:25 PM CET
Aker BioMarine ASA Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -22.6 | -22.8 | 182.6 | -9 | 10 | -8 |
Depreciation & Amortization | 24 | 22.9 | 42.8 | 22.6 | 49.2 | 51 |
Other Amortization | - | - | - | - | 2.2 | 2 |
Loss (Gain) From Sale of Assets | - | - | - | 0.9 | - | - |
Asset Writedown & Restructuring Costs | 0.1 | 0.1 | 1.2 | - | - | 5.8 |
Loss (Gain) on Equity Investments | 2.4 | 2.4 | - | 3 | - | - |
Other Operating Activities | -5.5 | -7.9 | 9.5 | -22.4 | -8.3 | -16.6 |
Change in Accounts Receivable | -5.8 | -5.8 | -18.7 | 23 | -38 | -31.6 |
Change in Other Net Operating Assets | -3.6 | - | - | - | - | - |
Operating Cash Flow | 4.3 | 4.2 | 12.2 | 47.4 | 15.1 | 2.6 |
Operating Cash Flow Growth | 53.57% | -65.57% | -74.26% | 213.91% | 480.77% | - |
Capital Expenditures | -7.3 | -6.3 | -17.4 | -45.9 | -40.5 | -78.7 |
Cash Acquisitions | - | - | -0.7 | - | -11.1 | - |
Divestitures | -7.3 | -7.3 | 404.1 | 0.6 | - | - |
Sale (Purchase) of Intangibles | -2.3 | -2.8 | -5.7 | -3.4 | -5.6 | -2.4 |
Other Investing Activities | 0.1 | - | 0.1 | 0.1 | - | - |
Investing Cash Flow | -17.4 | -17 | 379.4 | -48.9 | -56.4 | -81.1 |
Short-Term Debt Issued | - | 16.3 | 3.5 | - | - | - |
Long-Term Debt Issued | - | - | 150.7 | 40 | 66.5 | 339.2 |
Total Debt Issued | 175.7 | 16.3 | 154.2 | 40 | 66.5 | 339.2 |
Short-Term Debt Repaid | - | - | - | -18.7 | - | - |
Long-Term Debt Repaid | - | -1.6 | -185 | -14.6 | -14.2 | -260.3 |
Total Debt Repaid | -158.8 | -1.6 | -185 | -33.3 | -14.2 | -260.3 |
Net Debt Issued (Repaid) | 16.9 | 14.7 | -30.8 | 6.7 | 52.3 | 78.9 |
Issuance of Common Stock | 0.2 | - | - | - | 0.2 | - |
Other Financing Activities | -0.2 | -0.1 | - | - | - | - |
Financing Cash Flow | 16.9 | 14.6 | -404 | 6.7 | 52.5 | 78.9 |
Miscellaneous Cash Flow Adjustments | - | 0.1 | -0.1 | - | - | - |
Net Cash Flow | 3.8 | 1.9 | -12.5 | 5.2 | 11.2 | 0.4 |
Free Cash Flow | -3 | -2.1 | -5.2 | 1.5 | -25.4 | -76.1 |
Free Cash Flow Margin | -1.34% | -0.96% | -2.61% | 0.76% | -9.16% | -29.04% |
Free Cash Flow Per Share | -0.03 | -0.02 | -0.06 | 0.02 | -0.29 | -0.87 |
Cash Interest Paid | 15.6 | 15.8 | 24.3 | 29.7 | 17.6 | 12.8 |
Cash Income Tax Paid | - | - | - | 0.7 | 2.8 | -3.3 |
Levered Free Cash Flow | 31.33 | 19.71 | 80.54 | -24.85 | -34.7 | -49.05 |
Unlevered Free Cash Flow | 43.08 | 28.4 | 82.1 | -12.54 | -22.01 | -40.49 |
Change in Working Capital | -9.4 | -5.8 | -18.7 | 23 | -38 | -31.6 |